IMMUNOLOGIC STUDY OF HUMAN HLA AND MOUSE H-2 ANTIGENS
人 HLA 和小鼠 H-2 抗原的免疫学研究
基本信息
- 批准号:3124464
- 负责人:
- 金额:$ 34.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1974
- 资助国家:美国
- 起止时间:1974-10-01 至 1989-11-30
- 项目状态:已结题
- 来源:
- 关键词:B lymphocyte Coxsackievirus HY antigen affinity chromatography antibody dependent killer cell antibody formation antibody specificity antigen antibody reaction antileukocyte isoantibody cell sorting clone cells electrofocusing fluorescence glycoproteins helper T lymphocyte histocompatibility antigens human tissue hybridomas immune tolerance /unresponsiveness immunochemistry immunodeficiency isoantibody laboratory mouse laboratory rabbit laboratory rat lymphoblast macrophage major histocompatibility complex measles membrane proteins microorganism classification monoclonal antibody mutagens plaque assay
项目摘要
The objective is to gain precise knowledge of certain cell surface markers
especially those of lymphoid cells, and how each can serve as a
differentiation signal or trigger the activities of another cell. Most of
the effort is directed at components of the major histocompatibility
complex of man, HLA, which includes two distinct types of antigen, Class I
and Class II. Only 3 Class I molecules have been identified although over
30 genes exist. One of our aims is to determine if other genes in this
cluster (which we call a congener) are operational in cells of certain
tissue such as thymus or vascular endothelium or if some develop only at
specific stages of differentiation. Another aim is to produce monoclonal
antibodies to the Class I and Class II antigens. The Class II congener
includes at least 9 functioning genes but only 3 or 4 of the products,
transmembranous glycoprotein heterodimers can clearly be distinguished.
Having produced monoclonal antibodies to at least some of the individual
Class II glycoproteins and to the 2 or more epitopes probably carried by
each, we wish to know if each molecule has separate function and we ask the
complementary question "do the different epitopes of the same molecule even
have different function". We believe that the answers to these questions
will help us understand why some people form antibodies after transfusion
and some do not, why some reject kidneys and others do not, and how we
might, through such detailed analyses understand and control immune
responses in health and in diseases such as AIDS and autoimmunity. Since
we can learn about cellular function by an analysis of mutant cells, we
propose to screen for somatic mutants. We shall also look for new markers
of B lymphocytes and plasma cells. In a separate series of experiments in
mice we plan to study the way that the MHC molecules are transported to the
surface of the phagocytic cell since this may help us understand the way
that highly complex molecules function as antigens.
目的是获得某些细胞表面标记的精确知识
尤其是淋巴样细胞的人,以及如何用作
分化信号或触发另一个单元的活动。 大多数
这项工作针对主要组织相容性的组成部分
人类的复杂HLA,其中包括两种不同类型的抗原,I类
和II级。 尽管已经确定了3类I类分子
存在30个基因。 我们的目的之一是确定是否有其他基因
群集(我们称为同类物)在某些细胞中运行
组织,例如胸腺或血管内皮,或者仅在
特定的分化阶段。 另一个目的是产生单克隆
I类和II类抗原的抗体。 II级同类
包括至少9个功能基因,但只有3或4个产品,
可以清楚区分透射糖蛋白异二聚体。
产生了至少某些个体的单克隆抗体
II类糖蛋白和2个或更多表位可能由
每个人都希望知道每个分子是否具有分开的功能,我们询问
互补的问题“甚至是同一分子的不同表位
具有不同的功能”。我们相信这些问题的答案
将帮助我们理解为什么有些人在输血后形成抗体
有些人没有,为什么有些人拒绝肾脏和其他人没有,以及我们如何
可以通过这样的详细分析理解和控制免疫
健康和艾滋病和自身免疫等疾病的反应。 自从
我们可以通过分析突变细胞来了解细胞功能,我们
建议筛选体细胞突变体。 我们还将寻找新标记
B淋巴细胞和浆细胞。 在单独的一系列实验中
我们计划研究MHC分子转运到该的小鼠
吞噬细胞的表面,因为这可能有助于我们了解方式
该高度复杂的分子充当抗原。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
D. BERNARD AMOS其他文献
D. BERNARD AMOS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('D. BERNARD AMOS', 18)}}的其他基金
FUNDAMENTALS OF THE MECHANISMS OF HOMOGRAFT IMMUNITY
同种移植物免疫机制的基础知识
- 批准号:
3076223 - 财政年份:1977
- 资助金额:
$ 34.33万 - 项目类别:
FUNDAMENTALS OF THE MECHANISMS OF HOMOGRAFT IMMUNITY
同种移植物免疫机制的基础知识
- 批准号:
3076222 - 财政年份:1977
- 资助金额:
$ 34.33万 - 项目类别:
IMMUNOLOGIC STUDY OF HUMAN HLA AND MOUSE H-2 ANTIGENS
人 HLA 和小鼠 H-2 抗原的免疫学研究
- 批准号:
3124465 - 财政年份:1974
- 资助金额:
$ 34.33万 - 项目类别:
相似国自然基金
基于人群的儿童肠道病毒enterovirus 71和coxsackievirus A16感染的血清流行病学前瞻性研究
- 批准号:81473031
- 批准年份:2014
- 资助金额:70.0 万元
- 项目类别:面上项目
相似海外基金
Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes
确定 1 型糖尿病中 IFIH1 疾病相关变异对 β 细胞和免疫反应的机制
- 批准号:
10903049 - 财政年份:2023
- 资助金额:
$ 34.33万 - 项目类别:
Dynamic analysis of beta cell attacks in response to virus infection in Human pancreatic slices
人胰腺切片中β细胞响应病毒感染的攻击的动态分析
- 批准号:
10674127 - 财政年份:2023
- 资助金额:
$ 34.33万 - 项目类别:
Bacterial-mediated enhancement of Coxsackievirus
细菌介导的柯萨奇病毒增强
- 批准号:
10873407 - 财政年份:2022
- 资助金额:
$ 34.33万 - 项目类别:
Interaction between coxsackievirus and the cGAS-STING innate immune pathway
柯萨奇病毒与 cGAS-STING 先天免疫通路之间的相互作用
- 批准号:
574467-2022 - 财政年份:2022
- 资助金额:
$ 34.33万 - 项目类别:
University Undergraduate Student Research Awards
Bacterial-mediated enhancement of Coxsackievirus
细菌介导的柯萨奇病毒增强
- 批准号:
10634743 - 财政年份:2022
- 资助金额:
$ 34.33万 - 项目类别: